11 March 2019 | News
A total of 1,205 students participated in CEP in 2018 by enrolling in one or more of the six available programmes.
Medicines Australia recently recognised the extraordinary talent in the Australian Pharmaceutical sector workforce at the 22nd Annual Continuing Education Programme (CEP) Awards.
This mandatory programme highlights the innovative pharmaceutical industry’s diligent commitment to ethical conduct and to the training and supporting the highly skilled and dedicated Medical Representatives. A total of 1,205 students participated in CEP in 2018 by enrolling in one or more of the six available programmes.
These representatives of the innovative pharmaceutical industry have the important job of ensuring the dialogue between the companies who make the medicines and the doctors that prescribe them is productive, balanced and ethical.
The CEP Award winners, and all those who participated in the programmes have shown their commitment to providing accurate, balanced information in an ethical manner that will enhance the quality use of medicines in Australia.
CEP award recipients:
Code of Conduct – Outstanding Achievement Award
This award is presented to the candidate who achieves the highest mark in Program 1, the Code of Conduct Program.
Marita Warner – Otsuka
Continuing Education Program – Top Achievers
Winners in this category are students who achieve the highest aggregate marks in all five core Programs of the CEP.
The 2018 University of Tasmania Prize for Active Learning
A prize is awarded for each semester, based on the level and quality of students’ reflective assignments, exam results, active learning and participation in a Program.